By Dr Sunil Badve

Journal articles

LI J; BADVE SV; ZHOU Z; OH R; LEE M; PERKOVIC V; ZEEUW DD; MAHAFFEY KW; FULCHER G; MATTHEWS DR; NEAL B, 2019, 'The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program', Diabetes, 68, http://dx.doi.org/10.2337/db19-1216-p

Ha JT; Badve SV; Jun M, 2019, 'Recent evidence for direct oral anticoagulants in chronic kidney disease', Current Opinion in Nephrology and Hypertension, 28, pp. 251 - 261, http://dx.doi.org/10.1097/mnh.0000000000000493

Viecelli AK; Polkinghorne KR; Pascoe EM; Paul-Brent PA; Hawley CM; Badve SV; Cass A; Hooi LS; Kerr PG; Mori TA; Ong LM; Voss D; Johnson DW; Irish AB, 2019, 'Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial', PLoS ONE, 14, http://dx.doi.org/10.1371/journal.pone.0213274

Tennankore K; Zhao J; Karaboyas A; Bieber BA; Robinson BM; Morgenstern H; Jassal SV; Finkelstein FO; Kanjanabuch T; Cheawchanwattana A; Pisoni RL; Sloand JA; Perl J; Johnson D; Sanabria M; Kawanishi H; Kim Y-L; Davies S; Bernardo A; Pisoni R; Robinson B; Shen J; Badve S; Boudville N; Brown F; Chow J; Collins J; Morton R; Wilson S; Vychytil A; Van Biesen W; Figueiredo A; de Moraes T; Brunier G; Jain A; Jassal V; Nessim S; Oliver M; Price V; Quinn R; Szeto CC; Wang A; Fukasawa M; Ito Y; Ryuzaki M; Tomo T; Cueto Manzano A; Marshall M; Ljungman S; Boongird S; Boonyakrai C; Halue G; Sritippayawan S; Tatiyanupanwong S; Tungsanga K; Bowes E; Brown E; Fluck R; Goh BL; Hurst H; Wilkie M; Woodrow G; Bender F; Bernardini J; Chatoth D; Crabtree J; Finkelstein F; Ghaffari A; Mehrotra R; Piraino B; Schreiber M; Teitelbaum I, 2019, 'THE ASSOCIATION OF FUNCTIONAL STATUS WITH MORTALITY AND DIALYSIS MODALITY CHANGE: RESULTS FROM THE PERITONEAL DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (PDOPPS)', PERITONEAL DIALYSIS INTERNATIONAL, 39, pp. 103 - 111, http://dx.doi.org/10.3747/pdi.2018.00094

Lioufas N; Toussaint ND; Pedagogos E; Elder G; Badve SV; Pascoe E; Valks A; Hawley C; Block GA; Boudville NC; Campbell K; Cameron JD; Chen SSM; Faull RJ; Holt SG; Hooi LS; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Morrish A; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM; Badve S, 2019, 'Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study', BMJ Open, 9, pp. e024382, http://dx.doi.org/10.1136/bmjopen-2018-024382

Conley M; Toussaint ND; Pedagogos E; Lioufas N; Elder GJ; Badve SV; Hawley CM; Pascoe EM; Valks A; Campbell KL, 2019, 'SAT-224 ESTIMATES OF DIETARY PHOSPHATE CONSUMPTION AND COMMON FOOD SOURCES OF PHOSPHATE IN AUSTRALIANS WITH CHRONIC KIDNEY DISEASE', Kidney International Reports, 4, pp. S100 - S100, http://dx.doi.org/10.1016/j.ekir.2019.05.259

YEUNG WCG; Talbot B; Shah N; Palmer S; Mangos G; Gallagher M; Toussaint N; Badve S, 2019, 'SUN-292 BENEFITS AND HARMS OF VITAMIN D COMPOUNDS IN ADULTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', Kidney International Reports, 4, pp. S281 - S281, http://dx.doi.org/10.1016/j.ekir.2019.05.797

Tiku A; Badve SV; Johnson DW, 2018, 'Urate-Lowering Therapy for Preventing Kidney Disease Progression: Are We There Yet?', American Journal of Kidney Diseases, 72, pp. 776 - 778, http://dx.doi.org/10.1053/j.ajkd.2018.07.022

Htay H; Johnson DW; Wiggins KJ; Badve SV; Craig JC; Strippoli GFM; Cho Y, 2018, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD007554.pub3

Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S, 2018, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD011798.pub2

See EJ; Johnson DW; Hawley CM; Pascoe EM; Badve SV; Boudville N; Clayton PA; Sud K; Polkinghorne KR; Borlace M; Cho Y, 2018, 'Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study', American Journal of Kidney Diseases, 72, pp. 188 - 197, http://dx.doi.org/10.1053/j.ajkd.2017.10.019

Htay H; Cho Y; Pascoe EM; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW, 2018, 'Outcomes of acinetobacter peritonitis in peritoneal dialysis patients: A multicenter registry analysis', Peritoneal Dialysis International, 38, pp. 257 - 265, http://dx.doi.org/10.3747/pdi.2017.00199

Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW, 2018, 'Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry', American Journal of Kidney Diseases, 71, pp. 814 - 821, http://dx.doi.org/10.1053/j.ajkd.2017.10.017

See E; Johnson D; Hawley C; Pascoe E; Badve S; Boudville N; Clayton P; Sud K; Polkinghorne K; Borlace M; Cho Y, 2018, 'FP468RISK PREDICTORS AND CAUSES OF TECHNIQUE FAILURE WITHIN THE FIRST YEAR OF PERITONEAL DIALYSIS', Nephrology Dialysis Transplantation, 33, pp. i194 - i194, http://dx.doi.org/10.1093/ndt/gfy104.fp468

Jegatheesan D; Johnson DW; Cho Y; Pascoe EM; Darssan D; Htay H; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Nadeau-Fredette AC, 2018, 'The relationship between body mass index and organism-specific peritonitis', Peritoneal Dialysis International, 38, pp. 206 - 214, http://dx.doi.org/10.3747/pdi.2017.00188

Wong ATY; Mannix C; Grantham JJ; Allman-Farinelli M; Badve SV; Boudville N; Byth K; Chan J; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Haloob I; Harris DCH; Hawley CM; Hill J; Howard K; Howell M; Jiang SH; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Peduto A; Rangan A; Roger SD; Sud K; Torres V; Vliayuri E; Rangan GK, 2018, 'Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)', BMJ Open, 8, pp. e018794, http://dx.doi.org/10.1136/bmjopen-2017-018794

Htay H; Cho Y; Pascoe EM; Darssan D; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW, 2017, 'Outcomes of corynebacterium peritonitis: A multicenter registry analysis', Peritoneal Dialysis International, 37, pp. 619 - 626, http://dx.doi.org/10.3747/pdi.2017.00028

Viecelli AK; Pascoe EM; Polkinghorne KR; Hawley CM; Paul-Brent PA; Badve SV; Cass A; Johnson DW; Kerr PG; Mori TA; Scaria A; Hooi LS; Ong LM; Irish AB, 2017, 'Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study', Nephrology, 22, pp. 823 - 824, http://dx.doi.org/10.1111/nep.12823

Wong G; Au E; Badve SV; Lim WH, 2017, 'Breast Cancer and Transplantation', American Journal of Transplantation, 17, pp. 2243 - 2253, http://dx.doi.org/10.1111/ajt.14368

Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; Liu X; McTaggart S; Morrish AT; Playford G; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW, 2017, 'Representativeness of honeypot trial participants to Australasian PD patients', Peritoneal Dialysis International, 37, pp. 516 - 522, http://dx.doi.org/10.3747/pdi.2016.00065

Yeung WC; Badve SV; Pascoe E; Hawley CM; Clayton PA; McDonald SP; Lim WH; Wong G; Chadban SJ; Campbell SB; Johnson DW, 2017, 'TEMPORAL TRENDS IN CLINICAL OUTCOMES OF KIDNEY TRANSPLANTATION FROM 1996 TO 2013 IN AUSTRALIA AND NEW ZEALAND', NEPHROLOGY, 22, pp. 91 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408833200309&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW, 2017, 'Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysis', Clinical Journal of the American Society of Nephrology, 12, pp. 1090 - 1099, http://dx.doi.org/10.2215/CJN.12321216

Gummer J; Trengove R; Pascoe EM; Badve SV; Cass A; Clarke P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; Olynyk JK; Ferrari P, 2017, 'Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial', Nephrology, 22, pp. 548 - 554, http://dx.doi.org/10.1111/nep.12815

See E; Johnson D; Hawley C; Pascoe E; Darssan D; Clayton P; Borlace M; Badve S; Sud K; Boudville N; Cho Y, 2017, 'EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS', NEPHROLOGY DIALYSIS TRANSPLANTATION, 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000469797101230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Palmer S; Mavridis D; Nicolucci A; Craig J; Tonelli M; Johnson D; De Berardis G; Ruospo M; Natale P; Saglimbene V; Badve S; Cho Y; Nadeau-Fredette A-C; Burke M; Faruque L; Lloyd A; Ahmad N; Tiv S; Liu Y; Wiebe N; Strippoli G, 2017, 'SP427GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS', Nephrology Dialysis Transplantation, 32, pp. iii264 - iii265, http://dx.doi.org/10.1093/ndt/gfx149.sp427

See E; Johnson D; Hawley C; Pascoe E; Darssan D; Clayton P; Borlace M; Badve S; Sud K; Boudville N; Cho Y, 2017, 'SP493EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS', Nephrology Dialysis Transplantation, 32, pp. iii294 - iii294, http://dx.doi.org/10.1093/ndt/gfx151.sp493

Irish AB; Viecelli AK; Hawley CM; Hooi LS; Pascoe EM; Paul-Brent PA; Badve SV; Mori TA; Cass A; Kerr PG; Voss D; Ong LM; Polkinghorne KR, 2017, 'Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: A randomized clinical trial', Nieren- und Hochdruckkrankheiten, 46, pp. 172 - 173

Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S, 2017, 'Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients', Cochrane Database of Systematic Reviews, 2017, http://dx.doi.org/10.1002/14651858.CD009966.pub2

Irish AB; Viecelli AK; Hawley CM; Hooi LS; Pascoe EM; Paul-Brent PA; Badve SV; Mori TA; Cass A; Kerr PG; Voss D; Ong LM; Polkinghorne KR, 2017, 'Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis a randomized clinical trial', JAMA Internal Medicine, 177, pp. 184 - 193, http://dx.doi.org/10.1001/jamainternmed.2016.8029

Chan S; Cho Y; Koh YH; Boudville NC; Clayton PA; McDonald SP; Pascoe EM; Francis RS; Mudge DW; Borlace M; Badve SV; Sud K; Hawley CM; Johnson DW, 2017, 'Association of socio-economic position with technique failure and mortality in australian non-indigenous peritoneal dialysis patients', Peritoneal Dialysis International, 37, pp. 397 - 406, http://dx.doi.org/10.3747/pdi.2016.00209

Roberts MA; Darssan D; Badve SV; Carroll RP; Fahim MA; Haluska BA; Hawley CM; Isbel NM; Marshall MR; Pascoe EM; Pedagogos E; Pilmore HL; Snelling P; Stanton T; Tan KS; Tonkin AM; Vergara LA; Ierino FL, 2017, 'Carvedilol and cardiac biomarkers in dialysis patients: Secondary analysis of a randomized controlled trial', Kidney and Blood Pressure Research, 42, pp. 1033 - 1044, http://dx.doi.org/10.1159/000485589

Lim WH; Badve SV; Wong G, 2017, 'Long-term allograft and patient outcomes of kidney transplant recipients with and without incident cancer - A population cohort study', Oncotarget, 8, pp. 77771 - 77782, http://dx.doi.org/10.18632/oncotarget.20781

Lan PG; Clayton PA; Johnson DW; McDonald SP; Borlace M; Badve SV; Sud K; Boudville N, 2016, 'Duration of hemodialysis following peritoneal dialysis cessation in Australia and New Zealand: Proposal for a standardized definition of technique failure', Peritoneal Dialysis International, 36, pp. 623 - 630, http://dx.doi.org/10.3747/pdi.2015.00218

Badve SV; Pascoe EM; Burke M; Clayton PA; Campbell SB; Hawley CM; Lim WH; McDonald SP; Wong G; Johnson DW, 2016, 'Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients', Clinical Journal of the American Society of Nephrology, 11, pp. 1845 - 1855, http://dx.doi.org/10.2215/CJN.00190116

Badve SV; Palmer SC; Strippoli GFM; Roberts MA; Teixeira-Pinto A; Boudville N; Cass A; Hawley CM; Hiremath SS; Pascoe EM; Perkovic V; Whalley GA; Craig JC; Johnson DW, 2016, 'The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis', American Journal of Kidney Diseases, 68, pp. 554 - 563, http://dx.doi.org/10.1053/j.ajkd.2016.03.418

Nadeau-Fredette AC; Johnson DW; Hawley CM; Pascoe EM; Cho Y; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP, 2016, 'Center-specific factors associated with peritonitis risk—a multi-center registry analysis', Peritoneal Dialysis International, 36, pp. 509 - 518, http://dx.doi.org/10.3747/pdi.2015.00146

Badve SV; Palmer SC; Hawley CM; Pascoe EM; Strippoli GFM; Johnson DW, 2016, 'Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials', Nephrology Dialysis Transplantation, 31, pp. 1425 - 1436, http://dx.doi.org/10.1093/ndt/gfv269

Palmer SC; Mavridis D; Nicolucci A; Johnson DW; Tonelli M; Craig JC; Maggo J; Gray V; De Berardis G; Ruospo M; Natale P; Saglimbene V; Badve SV; Cho Y; Nadeau-Fredette AC; Burke M; Faruque L; Lloyd A; Ahmad N; Liu Y; Tiv S; Wiebe N; Strippoli GFM, 2016, 'Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes a meta-analysis', JAMA - Journal of the American Medical Association, 316, pp. 313 - 324, http://dx.doi.org/10.1001/jama.2016.9400

Young V; Balaam S; Orazio L; Bates A; Badve SV; Johnson DW; Campbell KL, 2016, 'Appetite predicts intake and nutritional status in patients receiving peritoneal dialysis', Journal of Renal Care, 42, pp. 123 - 131, http://dx.doi.org/10.1111/jorc.12156

Roberts MA; Pilmore HL; Ierino FL; Badve SV; Cass A; Garg AX; Isbel NM; Krum H; Pascoe EM; Perkovic V; Scaria A; Tonkin AM; Vergara LA; Hawley CM; Levin A; Hare D; Martin A; Wheeler DC; Fulcher G; Brown H; Colquhoun D; Korczyk D; Mather A; Wong A; Bisscheroux P; Gillies A; Garvey L; Tan KS; Lennan E; Pitkin M; Ahearn K; Carroll RP; Scott E; Cooper B; Pearse J; Snelling P; Burman J; Hand S; Pedagogos E; Karschimkus C; Pilmore A; Walker R; Ellis G; Marshall MR; Paul C; Johnson D; Helyar J; Morrish A; Paul-Brent PA; Reidlinger D; Zhang L, 2016, 'The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) feasibility study: A randomized controlled trial', American Journal of Kidney Diseases, 67, pp. 902 - 911, http://dx.doi.org/10.1053/j.ajkd.2015.10.029

Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW, 2016, 'Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study', Nephrology, 21, pp. 387 - 396, http://dx.doi.org/10.1111/nep.12629

Viecelli AK; Pascoe EM; Polkinghorne KR; Hawley CM; Paul-Brent PA; Badve SV; Cass A; Johnson DW; Kerr PG; Mori TA; Scaria A; Hooi SL; Ong ML; Irish AB, 2016, 'Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study', Nephrology, 21, pp. 217 - 228, http://dx.doi.org/10.1111/nep.12573

Zhang L; Coombes J; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW, 2016, 'The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial', Redox Report, 21, pp. 14 - 23, http://dx.doi.org/10.1179/1351000215Y.0000000022

Sukkar L; Hong D; Wong MG; Badve SV; Rogers K; Perkovic V; Walsh M; Yu X; Hillis GS; Gallagher M; Jardine M, 2016, 'Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: Systematic review and meta-analysis', BMJ (Online), 355, http://dx.doi.org/10.1136/bmj.i5599

Zhang L; Lee G; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW, 2016, 'Long-term outcomes of end-stage kidney disease for patients with lupus nephritis', Kidney International, 89, pp. 1337 - 1345, http://dx.doi.org/10.1016/j.kint.2016.02.014

Sukkar L; Hong D; Wong MG; Badve SV; Perkovic V; Yu X; Hillis GS; Gallagher M; Jardine M, 2016, 'MP221EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS', Nephrology Dialysis Transplantation, 31, pp. i413 - i413, http://dx.doi.org/10.1093/ndt/gfw187.27

Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; De Zoysa J; Isbel NM; McTaggart S; Morrish AT; Geoffrey Playford E; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW, 2015, 'The effect of exit-site antibacterial honey versus nasal mupirocin prophylaxis on the microbiology and outcomes of peritoneal dialysis-associated peritonitis and exit-site infections: A sub-study of the Honeypot trial', Peritoneal Dialysis International, 35, pp. 712 - 721, http://dx.doi.org/10.3747/pdi.2014.00206

Mallett A; Tang W; Hart G; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Clayton PA; Johnson DW, 2015, 'End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy-Outcomes in 66 consecutive ANZDATA registry cases', American Journal of Nephrology, 42, pp. 177 - 184, http://dx.doi.org/10.1159/000440815

Azzam O; Sud K; Clayton P; Johnson D; Badve S; Borlace M; Mcdonald S; Boudville N, 2015, 'DISPARITIES IN SURVIVAL OF DIALYSIS PATIENTS IN AUSTRALIA BASED UPON ETHNICITY AND COUNTRY OF BIRTH', NEPHROLOGY, 20, pp. 56 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360217000142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Burke M; Clayton P; Campbell SB; Hawley CM; Lim WH; Mcdonald SP; Pascoe E; Wong G; Johnson DW, 2015, 'MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS AND CLINICAL OUTCOMES IN ADULT KIDNEY TRANSPLANT RECIPIENTS', NEPHROLOGY, 20, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360217000115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page